company background image
2235

MicroTech Medical (Hangzhou) SEHK:2235 Stock Report

Last Price

HK$7.25

Market Cap

HK$3.1b

7D

-1.4%

1Y

n/a

Updated

30 Sep, 2022

Data

Company Financials +
2235 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance0/6
Financial Health5/6
Dividends0/6

2235 Stock Overview

MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables in the People’s Republic of China and internationally.

MicroTech Medical (Hangzhou) Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MicroTech Medical (Hangzhou)
Historical stock prices
Current Share PriceHK$7.25
52 Week HighHK$31.70
52 Week LowHK$6.28
Beta0
1 Month Change-7.17%
3 Month Change-26.77%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-76.23%

Recent News & Updates

Shareholder Returns

2235HK Medical EquipmentHK Market
7D-1.4%0.9%-4.4%
1Yn/a-56.0%-28.8%

Return vs Industry: Insufficient data to determine how 2235 performed against the Hong Kong Medical Equipment industry.

Return vs Market: Insufficient data to determine how 2235 performed against the Hong Kong Market.

Price Volatility

Is 2235's price volatile compared to industry and market?
2235 volatility
2235 Average Weekly Movement4.5%
Medical Equipment Industry Average Movement7.1%
Market Average Movement6.4%
10% most volatile stocks in HK Market12.6%
10% least volatile stocks in HK Market3.1%

Stable Share Price: 2235 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 2235's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011664Pan Zhenghttps://www.microtechmd.com

MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables in the People’s Republic of China and internationally. Its products include Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, blood glucose monitoring systems, and closed-loop artificial pancreas. The company is also involved in engineering and technology research experimentation and development activities.

MicroTech Medical (Hangzhou) Co., Ltd. Fundamentals Summary

How do MicroTech Medical (Hangzhou)'s earnings and revenue compare to its market cap?
2235 fundamental statistics
Market CapHK$3.09b
Earnings (TTM)-HK$40.83m
Revenue (TTM)HK$180.59m

17.1x

P/S Ratio

-75.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
2235 income statement (TTM)
RevenueCN¥163.82m
Cost of RevenueCN¥92.67m
Gross ProfitCN¥71.15m
Other ExpensesCN¥108.19m
Earnings-CN¥37.04m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.087
Gross Margin43.43%
Net Profit Margin-22.61%
Debt/Equity Ratio0%

How did 2235 perform over the long term?

See historical performance and comparison